Vassar Brothers Hospital

Vassar Brothers Hospital was paid $39.35M by Medicaid between Jan 2018 and Dec 2024, across 341 billing codes. Its largest line is G0378, Hospital observation service, per hour — 9.4% of everything it billed.

33Billing provider infoVASSAR BROTHERS HOSPITAL
POUGHKEEPSIE, NY 12601

33aNPI1740233899assigned 05/18/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$39.35M

24GClaims649,793

24DCodes billed341

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#38 of 231

Median peer was paid$561K

This provider vs. median70×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	594	$5K
2019	59,878	$3.01M
2020	113,266	$6.25M
2021	141,381	$8.03M
2022	117,953	$7.26M
2023	117,041	$8.07M
2024incomplete	99,680	$6.73M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0378	Hospital observation service, per hour	9.4%	4,174	3,458	$3.71M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.0%	18,401	17,276	$3.14M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	7.3%	16,053	15,027	$2.89M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.8%	13,018	12,190	$2.27M
96361	Intravenous infusion, hydration; each additional hour	5.1%	6,808	6,020	$2.02M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	4.3%	5,170	5,067	$1.68M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.1%	4,740	4,649	$1.24M
70450	Computed tomography, head or brain; without contrast material	3.1%	4,485	4,324	$1.24M
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	3.1%	2,439	2,392	$1.20M
80053	Comprehensive metabolic panel	2.6%	49,911	43,773	$1.04M
77412		2.4%	1,239	121	$962K
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.1%	4,906	4,555	$840K

329 more codes

77336		2.1%	873	$837K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	2.0%	14,982	$772K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.9%	3,416	$753K
59025	Fetal non-stress test	1.9%	2,612	$730K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.7%	7,777	$654K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.6%	2,244	$612K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.4%	939	$561K
93017		1.1%	2,691	$451K
41899	Unlisted procedure, dentoalveolar structures	1.1%	302	$437K
71275	Computed tomographic angiography, chest, with contrast material	1.0%	1,685	$410K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.0%	1,848	$409K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	2,218	$387K
93975		<1%	833	$380K
93970		<1%	805	$377K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,391	$367K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,048	$347K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,823	$314K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,782	$304K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	909	$298K
76801		<1%	2,558	$238K
93225		<1%	1,187	$234K
99204	Doctor's office visit, new patient (more involved)	<1%	1,407	$215K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	4,169	$214K
86850		<1%	5,846	$211K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	3,376	$201K
99203	Doctor's office visit, new patient (routine)	<1%	1,293	$201K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,564	$179K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,099	$164K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,494	$155K
86901		<1%	5,845	$153K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,035	$141K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	846	$133K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,614	$118K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	3,735	$116K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,037	$115K
86900		<1%	5,853	$113K
83880		<1%	3,180	$106K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	2,688	$106K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	1,659	$106K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	1,534	$103K
93226		<1%	1,072	$102K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,474	$98K
93296		<1%	1,174	$95K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	2,254	$93K
97161		<1%	814	$93K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,605	$91K
36415	Collection of venous blood by venipuncture	<1%	15,623	$91K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	287	$90K
93971		<1%	1,031	$87K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	96	$80K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	394	$80K
84443	Thyroid stimulating hormone (TSH)	<1%	9,727	$79K
76830	Ultrasound, transvaginal	<1%	1,692	$78K
70496		<1%	254	$75K
78815	Positron emission tomography (PET) for limited area imaging	<1%	177	$75K
71250		<1%	851	$75K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	38,365	$72K
99406		<1%	2,069	$71K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	70	$70K
86618		<1%	3,177	$69K
80048	Basic metabolic panel (calcium, ionized)	<1%	4,331	$69K
80061	Lipid panel	<1%	9,938	$68K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	2,581	$67K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,722	$64K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,971	$63K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	3,371	$63K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,232	$63K
96367		<1%	477	$62K
77065	Tomosynthesis, mammo	<1%	763	$62K
85610		<1%	14,786	$60K
76641		<1%	2,268	$60K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,062	$59K
74183		<1%	183	$57K
96415		<1%	91	$54K
76819	Fetal biophysical profile; without non-stress testing	<1%	816	$54K
82607		<1%	4,271	$53K
74174		<1%	166	$49K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,644	$49K
76770		<1%	146	$47K
J1756	Injection, iron sucrose, 1 mg	<1%	833	$46K
77066	Tomosynthesis, mammo	<1%	673	$44K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	342	$42K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,397	$40K
88342		<1%	748	$37K
99213	Doctor's office visit, returning patient (routine)	<1%	140	$37K
76642		<1%	1,792	$36K
81025		<1%	10,359	$35K
88304		<1%	719	$33K
87634		<1%	1,375	$33K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,693	$33K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	612	$33K
82728		<1%	2,403	$30K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	6,174	$28K
12001		<1%	57	$28K
77334		<1%	45	$28K
77280		<1%	30	$27K
76536		<1%	1,193	$27K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	908	$27K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,613	$26K
72125	Computed tomography, cervical spine; without contrast material	<1%	641	$25K
88307		<1%	278	$25K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	905	$25K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	198	$24K
71046	Radiologic examination, chest; 2 views	<1%	3,803	$24K
86803		<1%	2,250	$23K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	145	$23K
86780		<1%	1,943	$22K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	2,080	$21K
70486		<1%	295	$21K
84439		<1%	2,695	$20K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,101	$20K
82746		<1%	1,631	$19K
82803		<1%	1,031	$19K
94060		<1%	681	$18K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	11,445	$17K
72141		<1%	53	$16K
84153		<1%	841	$16K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	200	$15K
90715		<1%	508	$14K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	588	$14K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	10,054	$13K
84466		<1%	1,066	$13K
83735		<1%	8,558	$12K
77290		<1%	15	$11K
72197		<1%	38	$11K
97535	Self-care/home management training, each 15 minutes	<1%	202	$11K
83540		<1%	2,221	$11K
86617		<1%	491	$11K
87486		<1%	263	$11K
82378		<1%	720	$11K
82565		<1%	2,346	$11K
87340		<1%	988	$10K
77300		<1%	13	$10K
81001		<1%	7,999	$10K
86666		<1%	408	$10K
87077		<1%	1,786	$10K
86769		<1%	220	$10K
77080		<1%	183	$10K
94726		<1%	682	$10K
87625		<1%	355	$9K
94729		<1%	681	$9K
86762		<1%	577	$8K
77049		<1%	27	$8K
84702		<1%	1,826	$8K
84481		<1%	744	$8K
72100		<1%	1,184	$7K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	1,273	$7K
36430		<1%	18	$7K
87081		<1%	1,350	$7K
93880		<1%	56	$6K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	20	$6K
85027		<1%	3,227	$6K
87186		<1%	1,389	$6K
86140		<1%	2,377	$6K
87581		<1%	264	$6K
71271		<1%	248	$5K
86038		<1%	944	$5K
87660		<1%	345	$5K
73030		<1%	887	$5K
80047		<1%	220	$5K
83550		<1%	1,032	$5K
87510		<1%	325	$5K
85730		<1%	2,787	$5K
97803		<1%	244	$5K
87480		<1%	313	$5K
82570		<1%	1,071	$4K
80076		<1%	490	$4K
97162		<1%	29	$4K
70491		<1%	17	$4K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	27	$4K
71045	Radiologic examination, chest; single view	<1%	7,501	$4K
88341		<1%	138	$4K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	417	$4K
73562		<1%	596	$4K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	105	$4K
86480		<1%	62	$4K
88142		<1%	160	$4K
96375	Therapeutic injection; each additional sequential IV push	<1%	8,254	$3K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,774	$3K
77062		<1%	110	$3K
J1453	Injection, fosaprepitant, 1 mg	<1%	22	$3K
J2785	Injection, regadenoson, 0.1 mg	<1%	155	$3K
86431		<1%	552	$3K
29125		<1%	12	$3K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	122	$3K
76937		<1%	13	$3K
81003		<1%	4,349	$3K
83690		<1%	5,478	$2K
86376		<1%	163	$2K
86300		<1%	106	$2K
83615		<1%	679	$2K
76775		<1%	28	$2K
76882		<1%	62	$2K
88141		<1%	348	$2K
73630		<1%	401	$2K
73610		<1%	507	$2K
84484		<1%	8,296	$2K
87070		<1%	390	$2K
85379		<1%	2,661	$2K
86787		<1%	272	$2K
73130		<1%	366	$2K
86706		<1%	179	$2K
85652		<1%	1,870	$2K
87484		<1%	87	$2K
87468		<1%	87	$2K
97116		<1%	38	$2K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	4,765	$2K
84550		<1%	523	$2K
97802		<1%	57	$2K
85007		<1%	1,372	$2K
82947		<1%	1,616	$2K
97165		<1%	12	$2K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	13	$1K
76870		<1%	27	$1K
83001		<1%	64	$1K
72082		<1%	92	$1K
86753		<1%	117	$1K
84403		<1%	39	$1K
85651		<1%	638	$1K
83605		<1%	3,377	$1K
82784		<1%	55	$989.81
86800		<1%	74	$966.72
84703		<1%	1,458	$918.01
82550		<1%	716	$903.53
86765		<1%	62	$854.84
84100		<1%	1,738	$843.35
87205		<1%	392	$827.39
70498		<1%	75	$810.02
72040		<1%	143	$790.80
74018		<1%	224	$754.48
86235		<1%	40	$636.91
96402		<1%	13	$627.86
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	890	$623.12
J7030	Infusion, normal saline solution , 1000 cc	<1%	5,041	$621.91
76813		<1%	41	$621.66
86735		<1%	74	$601.78
84460		<1%	153	$580.44
93298		<1%	261	$579.96
87040		<1%	1,673	$576.47
86696		<1%	45	$574.20
88112		<1%	14	$573.38
84450		<1%	141	$541.04
82948		<1%	2,262	$522.59
84156		<1%	195	$415.82
72070		<1%	57	$392.78
84146		<1%	15	$379.68
99407		<1%	32	$375.13
82150		<1%	196	$361.88
80320		<1%	1,083	$346.11
73502		<1%	57	$316.97
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,724	$285.18
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	5,255	$275.40
73560		<1%	118	$269.84
86304		<1%	17	$257.86
96376		<1%	1,544	$251.78
83002		<1%	12	$228.78
J3475	Injection, magnesium sulfate, per 500 mg	<1%	318	$222.40
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	545	$213.43
83655		<1%	14	$207.55
77061		<1%	12	$201.69
82248		<1%	69	$201.49
73110		<1%	43	$199.25
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	6,578	$195.47
82533		<1%	15	$184.36
73564		<1%	14	$180.91
J1650	Injection, enoxaparin sodium, 10 mg	<1%	596	$180.84
86039		<1%	32	$167.44
72050		<1%	12	$165.16
84520		<1%	39	$165.02
J7050	Infusion, normal saline solution, 250 cc	<1%	764	$161.06
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	493	$137.88
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	4,262	$136.41
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,019	$134.13
82105		<1%	15	$122.73
J2704	Injection, propofol, 10 mg	<1%	3,538	$117.47
84480		<1%	17	$85.36
82043		<1%	15	$83.78
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,610	$83.11
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	407	$76.47
73080		<1%	26	$75.75
82950		<1%	40	$64.75
84436		<1%	12	$64.41
87207		<1%	49	$60.81
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	599	$60.77
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,570	$52.41
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,594	$51.17
73140		<1%	13	$50.85
85014		<1%	40	$50.04
86141		<1%	32	$48.18
74019		<1%	24	$43.20
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	318	$38.60
73600		<1%	15	$34.20
J1644	Injection, heparin sodium, per 1000 units	<1%	618	$32.92
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	2,514	$25.14
85018		<1%	26	$24.30
83721		<1%	12	$18.22
73090		<1%	15	$17.60
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	87	$17.26
85384		<1%	25	$15.87
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	793	$12.80
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	599	$8.62
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	1,886	$8.25
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	13	$6.29
C9113	Injection, pantoprazole sodium, per vial	<1%	138	$5.34
99152		<1%	42	$4.91
81015		<1%	135	$4.24
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	147	$1.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	55	$1.00
A4649	Surgical supply; miscellaneous	<1%	143	$0.78
S0119	Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)	<1%	43	$0.45
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	141	$0.31
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	62	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	57	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	43	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	19	$0.00
96417		0%	56	$0.00
84145		0%	27	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	14	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	36	$0.00
C1769	Guide wire	0%	342	$0.00
J2060	Injection, lorazepam, 2 mg	0%	85	$0.00
93297		0%	13	$0.00
80329		0%	157	$0.00
A4648	Tissue marker, implantable, any type, each	0%	25	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	20	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	28	$0.00
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	0%	43	$0.00
94644		0%	12	$0.00
S0020	Injection, bupivicaine hydrochloride, 30 ml	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDARCY, KAREN (VP ACCOUNTING & CORPORATE SERVICES)